Skip to Content
  • Revenues ($M)
    $19,959
  • Revenue Percent Change
    1.7%
  • Profits ($M)
    $2,408
  • Profits Percent Change
    0.7%
  • Assets ($M)
    $35,569
  • Employees
    41,275
  • Market Value — as of March 31, 2016 ($M)
    $79,535
  • Previous Rank
    151
  • Morning Consult Brand Index
    B-

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
David A. Ricks
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Indianapolis, IN
Websitehttp://www.lilly.com
Years on Fortune 500 List22
Employees41,275

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$19,9591.7%
Profits ($M)$2,4080.7%
Assets ($M)$35,569-
Total Stockholder Equity ($M)$14,571-
Market Value — as of March 31, 2016 ($M)$79,535-

Profit Ratios

Profit as % of Revenues12.1%
Profits as % of Assets6.8%
Profits as % of Stockholder Equity16.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.26
EPS % Change (from 2014)1.3%
EPS % Change (5 year annual rate)-13.2%
EPS % Change (10 year annual rate)2.2%

Total Return

Total Return to Investors (2015)25.3%
Total Return to Investors (5 year, annualized)23.8%
Total Return to Investors (10 year, annualized)8.4%